Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Reducing the effect of parasitic capacitance on implantable passive resonant sensors.

Drazan JF, Abdoun OT, Wassick MT, Marcus GA, Dahle R, Beardslee LA, Cady NC, Ledet EH.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:1930-1933. doi: 10.1109/EMBC.2016.7591100.

PMID:
28268705
2.

A simple sensing mechanism for wireless, passive pressure sensors.

Drazan JF, Wassick MT, Dahle R, Beardslee LA, Cady NC, Ledet EH.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:1890-1893. doi: 10.1109/EMBC.2016.7591090.

PMID:
28268696
3.

Tiotropium Respimat inhaler and the risk of death in COPD.

Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators.

N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30.

4.

Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting.

Søes-Petersen U, Kava T, Dahle R, Lei Y, Dam N.

Clin Respir J. 2011 Jul;5(3):173-82. doi: 10.1111/j.1752-699X.2010.00217.x. Epub 2010 Jul 15.

PMID:
21679353
5.

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators.

Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25.

6.

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.

Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT investigators.

Lancet. 2009 Oct 3;374(9696):1171-8. doi: 10.1016/S0140-6736(09)61298-8. Epub 2009 Aug 27.

PMID:
19716598
8.

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators.

N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.

9.

Gonadal development and associated changes in liver size and sexual steroids during the reproductive cycle of captive male and female Atlantic cod (Gadus morhua L.).

Dahle R, Taranger GL, Karlsen Ø, Kjesbu OS, Norberg B.

Comp Biochem Physiol A Mol Integr Physiol. 2003 Nov;136(3):641-53.

PMID:
14613792
10.

Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.

Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Hatlevoll R, Dahle R, Boye N, Wang M, Vigander T, Vilsvik J, Skovlund E, Hannisdal E, Aamdal S; Norwegian Lung Cancer Study Group.

J Clin Oncol. 2002 Dec 15;20(24):4665-72.

PMID:
12488411
11.

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group.

Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J.

Lancet. 1998 Mar 14;351(9105):773-80. Erratum in: Lancet 1998 Jun 27;351(9120):1968.

PMID:
9519948
12.

[Intruders or innovators. More women physicians?].

Dahle R.

Tidsskr Nor Laegeforen. 1993 Aug 30;113(20):2597-600. Norwegian.

PMID:
8236184
13.
14.

[Transbronchial lung biopsy].

Dahle R.

Tidsskr Nor Laegeforen. 1980 Jul 10;100(19-21):1227-9. Norwegian. No abstract available.

PMID:
7423452
15.

[Rehabilitation after myocardial infarct].

Dahle R, Gjølberg T.

Tidsskr Nor Laegeforen. 1979 May 20;99(14):696-9. Norwegian. No abstract available.

PMID:
462429
16.

[Hyposensitization in bronchial asthma. A follow-up study of patients].

Våla IJ, Dahle R.

Tidsskr Nor Laegeforen. 1973 Aug 10;93(21):1513-5. Norwegian. No abstract available.

PMID:
4766368

Supplemental Content

Loading ...
Support Center